Epidemiological assessment and therapeutic response in hypopharyngeal cancer
- PMID: 23929153
- PMCID: PMC9442406
- DOI: 10.5935/1808-8694.20130089
Epidemiological assessment and therapeutic response in hypopharyngeal cancer
Abstract
Despite the low incidence, diagnostic and therapeutic advances, hypopharyngeal cancer still has high mortality.
Objective: To evaluate retrospectively the epidemiological profile and response to surgery and radiation/chemotherapy of patients with hypopharyngeal cancer.
Method: We reviewed the medical records of 114 patients treated between 2002 and 2009 in a tertiary hospital with histopathological diagnosis of squamous cell carcinoma.
Results: The mean age of the patients was 57 years, 94.7% were males and 5.3% females, 98.2% were smokers and 92% consumed alcohol; 72% are illiterate or did not complete first grade schooling. The main complaints were: neck node (28%), pain and dysphagia (22%), odynophagia (12.2%), dysphonia (7.8%). The clinical staging was: I (1.7%), II (3.5%), III (18.4%), IV (76.3%). The treatment was carried out with radiotherapy and chemotherapy alone in 35%, with mean 2-year survival of 20% and 5-year survival of 18%; surgery followed by radiotherapy and chemotherapy in 22.8% with 2-year survival of 60.0% and 5 years of 55.0%; chemotherapy alone in 2.6%, and 39.4% without treatment.
Conclusion: Most patients already had advanced clinical stages and independent of the treatment option, had a low survival rate, confirming the poor prognosis of this neoplasm.
Figures
References
-
- Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base Report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(9):951–962. - PubMed
-
- Brasil. Ministério da Saúde. Instituto Nacional de Câncer Carcinoma epidermóide de cabeça e pescoço. Condutas do INCA/MS. Rev Bras Cancerol. 2001;47(4):361–376.
-
- Tuyns AJ, Estève J, Raymond L, Berrino F, Benhamou E, Blanchet F, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France) Int J Cancer. 1988;41(4):483–491. doi: 10.1002/ijc.2910410403. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
